ROOPA INDUSTRIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.03 INR | -1.01% |
|
-2.51% | +10.33% |
| Sales 2022 | 512M 6.13M | Sales 2023 | 762M 9.12M | Capitalization | 322M 3.86M |
|---|---|---|---|---|---|
| Net income 2022 | 10M 120K | Net income 2023 | 13M 156K | EV / Sales 2022 | 0.59 x |
| Net Debt 2022 | 105M 1.25M | Net Debt 2023 | 169M 2.03M | EV / Sales 2023 | 0.65 x |
| P/E ratio 2022 |
19.4
x | P/E ratio 2023 |
23.9
x | Employees | 59 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 36.27% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.01% | ||
| 1 week | -2.51% | ||
| Current month | -0.71% | ||
| 1 month | -8.02% | ||
| 3 months | -1.69% | ||
| 6 months | +13.36% | ||
| Current year | +10.33% |
1 week
55.55
61.14
1 month
50.2562.00
Current year
46.3673.20
1 year
37.4073.20
3 years
12.9092.75
5 years
6.8292.75
10 years
5.0092.75
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 01/98/01 | |
| Director of Finance/CFO | - | 01/20/01 | |
| Compliance Officer | - | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 01/98/01 | |
| Director/Board Member | 67 | 17/97/17 | |
| Director/Board Member | 68 | 03/15/03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 57.03 | -1.01% | 2 647 |
| 25/24/25 | 57.61 | +1.07% | 3,231 |
| 24/24/24 | 57 | -0.68% | 2,891 |
| 21/24/21 | 57.39 | -1.02% | 1,596 |
| 20/24/20 | 57.98 | -0.89% | 4,599 |
Delayed Quote Bombay S.E., June 26, 2024 at 03:30 pm IST
More quotes
Roopa Industries Limited is engaged in active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is engaged in the manufacturing of bulk drugs/drug intermediates. The Companyâs products include N,N- dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is a product used by the manufacturers of the Cephalosporin group of Antibiotics and Statins. It is used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to Agriculture. Glucosamine is a sheet anchor product that is a nutraceutical / nutritional supplement. Bromine And Its Derivatives offers agrochemicals, dyes, various organic and inorganic for medical & veterinary products, gasoline applications, water purification compounds, disinfectants, insecticides, and pesticides.
Sector
Pharmaceuticals
Calendar
12/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +10.33% | 5.43M | |
| +55.19% | 815B | |
| +45.22% | 654B | |
| -6.09% | 354B | |
| +21.92% | 337B | |
| +18.94% | 247B | |
| +3.23% | 229B | |
| +13.79% | 219B | |
| +10.86% | 171B | |
| -2.78% | 159B |
- Stock Market
- Equities
- ROOPAIND6 Stock
